Pressrelease 29 December 2006
US Patent Received for Diabetes Treatment
Patent appoved in US for treatment of Insulin Resistance. Glucox Biotech hereby announces the approval of the full patent application for the use of its target protein NAD(P)H-oxidase implicated in insulin resistance. The patent received will provide a strong commercial protection for pharmaceutical products proceeding within the company.
Download a pdf of the Pressrelease
Pressrelease 15 May 2007
Promising Results in Treatment with GLX
Pressrelease 29 December 2006
US Patent Received for Diabetes Treatment
Pressrelease 28 September 2006
Glucox' Unique Research Discovery Confirmed by US Scientist
Pressrelease 10 July 2006
Patent Application Submitted for the GLX Compounds
Pressrelease 5 June 2006
A Significant Preclinical Milestone Achieved
Pressrelease 7 February 2006
Positive Results from the First Time In Animal Study
Pressrelease 10 January 2006
Pressrelease 10 November 2005
Evaluation and Selection of Glucox Biotech' Lead Drug Candidates